Cited by 778Neonatal and fetal brain pathologyThermal Regulation in MedicineInfant Development and Preterm Care

Hypoxic-Ischemic Encephalopathy: A Review for the Clinician

Douglas-Escobar, Martha, Weiss, Michael D.·2015·JAMA Pediatrics

Abstract

IMPORTANCE: Hypoxic-ischemic encephalopathy (HIE) occurs in 1 to 8 per 1000 live births in developed countries. Historically, the clinician has had little to offer neonates with HIE other than systemic supportive care. Recently, the neuroprotective therapy of hypothermia has emerged as the standard of care, and other complementary therapies are rapidly transitioning from the basic science to clinical care. OBJECTIVE: To examine the pathophysiology of HIE and the state of the art for the clinical care of neonates with HIE. EVIDENCE REVIEW: We performed a literature review using the PubMed database. Results focused on reviews and articles published from January 1, 2004, through December 31, 2014. Articles published earlier than 2004 were included when appropriate for historical perspective. Our review emphasized evidence-based management practices for the clinician. FINDINGS: A total of 102 articles for critical review were selected based on their relevance to the incidence of HIE, pathophysiology, neuroimaging, placental pathology, biomarkers, current systemic supportive care, hypothermia, and emerging therapies for HIE and were reviewed by both of us. Seventy-five publications were selected for inclusion in this article based on their relevance to these topics. The publications highlight the emergence of serum-based biomarkers, placental pathology, and magnetic resonance imaging as useful tools to predict long-term outcomes. Hypothermia and systemic supportive care form the cornerstone of therapy for HIE. CONCLUSIONS AND RELEVANCE: The pathophysiology of HIE is now better understood, and treatment with hypothermia has become the foundation of therapy. Several neuroprotective agents offer promise when combined with hypothermia and are entering clinical trials.

Integrity signals

Registry

Crossref · 10.1001/jamapediatrics.2014.3269

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Emerging evidence highlights that factors such as hypocapnia, hyperoxia, extreme fluctuations in blood pressure and glucose are associated with worse outcomes in neonates with HIE.

    “Emerging evidence highlights that factors such as hypocapnia, hyperoxia, extreme fluctuations in blood pressure and glucose are associated with worse outcomes in this population (1, 4–8).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Douglas-Escobar, M., & Weiss, M. D.
Affiliations
  • Department of Pediatrics, University of California, San Francisco
  • University of Florida (US)
Venue
JAMA Pediatrics
Published
2015-04-01
Volume
169
Issue
4
Pages
397
ISSN
  • 1072-4710 (ISSN-L)
  • 2168-6203
OpenAlex
W2157633141
Cited by
778
References
68
Citations by year
2026: 65 · 2025: 91 · 2024: 108 · 2023: 94 · 2022: 89 · 2021: 98 · 2020: 85 · 2019: 57 · 2018: 36 · 2017: 27 · 2016: 22 · 2015: 6
FWCI
30.20
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Pediatrics and Adolescent Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Development and Preterm Care
Keywords
hypoxic-ischemic encephalopathy, neonatal brain injury, therapeutic hypothermia, neuroprotection, pathophysiology, serum biomarkers, placental pathology, magnetic resonance imaging, neuroimaging, long-term outcome prediction, neuroprotective agents
MeSH terms
Combined Modality Therapy, Female, Humans, Hypothermia, Induced, Infant, Newborn, Placenta, Pregnancy, Biomarkers, Neuroprotective Agents, Hypoxia-Ischemia, Brain, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review